Combination of dose escalation with technological advances (Intensity-Modulated and Image-Guided Radiotherapy) is not associated with increased morbidity for patients with prostate cancer

Strahlentherapie und Onkologie

Volumn 187, Issue 8, 2011, Pages 479-484

  Pinkawa, Michael ^a   Piroth, Marc D ^a   Holy, Richard ^a   Djukic, Victoria ^a   Klotz, Jens ^a   Krenkel, Barbara ^a   Eble, Michael J ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Conformal radiotherapy; Image guided radiotherapy; Intensity modulated radiotherapy; Prostate neoplasm; Quality of life

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; DEFECATION URGENCY; DOSIMETRY; DYSURIA; ERECTILE DYSFUNCTION; EXPANDED PROSTATE CANCER INDEX COMPOSITE; FATIGUE; FECES INCONTINENCE; HEMATOCHEZIA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PAINFUL DEFECATION; PENIS ERECTION; PROGNOSIS; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RECTUM HEMORRHAGE; SEXUAL FUNCTION; SEXUAL INTERCOURSE; URINARY TRACT FUNCTION;

AGED; AGED, 80 AND OVER; ALGORITHMS; ERECTILE DYSFUNCTION; FOLLOW-UP STUDIES; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM;

EID: 80052263107     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2249-z     Document Type: Article

References (30)

1. T. Akimoto H. Muramatsu M. Takahashi, et al. 2004 Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding Int J Radiat Oncol Biol Phys 60 1033 1039 15519772 10.1016/j.ijrobp.2004.07.393 (Pubitemid 39440786)
2. A. Al-Mamgani W.L. van Putten W.D. Heemsbergen, et al. 2008 Update of dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 72 980 988 18495377 10.1016/j.ijrobp.2008. 02.073
3. TM (b-mode acquisition and targeting) for prostate cancer Strahlenther Onkol 184 674 678 19107349 10.1007/s00066-008-1837-z
4. D.J. Brenner 2004 Fractionation and late rectal toxicity Int J Radiat Oncol Biol Phys 60 1013 1015 15519768 10.1016/j.ijrobp.2004.04.014 (Pubitemid 39440782)
5. R. de Crevoisier S.L. Tucker L. Dong, et al. 2005 Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy Int J Radiat Oncol Biol Phys 62 965 973 15989996 10.1016/j.ijrobp.2004.11.032 (Pubitemid 40884405)
6. G.O. De Meerleer L. Vakaet W. Gersem, et al. 2000 Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison Int J Radiat Oncol Biol Phys 47 639 648 10837946 10.1016/S0360-3016(00)00419-3 (Pubitemid 30317481)
7. C. Fiorino G. Sanguineti C. Cozzarini, et al. 2003 Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer Int J Radiat Oncol Biol Phys 57 953 962 14575825 10.1016/S0360-3016(03)00665-5 (Pubitemid 37324112)
8. P. Ghadjar N. Gwerder P. Manser, et al. 2010 High-dose (80 Gy) intensity-modulated radiation therapy with daily image guidance as primary treatment for localized prostate cancer Strahlenther Onkol 186 687 692 21136028 10.1007/s00066-010-2180-8
9. G. Goldner H. Bombosch H. Geinitz, et al. 2009 Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective austrian-german multicenter phase II trial Strahlenther Onkol 185 94 100 19240995 10.1007/s00066-009-1970-3
10. G. Goldner J. Dimopoulos C. Kirisits, et al. 2009 Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy Strahlenther Onkol 185 438 445 19714305 10.1007/s00066-2009-2033-5
11. G. Goldner B. Tomicek G. Becker, et al. 2007 Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients Int J Radiat Oncol Biol Phys 67 78 83 17189064 10.1016/j.ijrobp.2006.08.055 (Pubitemid 44959504)
12. M. Guckenberger S. Ok B. Polat, et al. 2010 Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer Strahlenther Onkol 186 535 543 20890743 10.1007/s00066-010-2144-z
13. International Commission on Radiation Units and Measurements (ICRU). Prescribing, recording and reporting photon beam therapy. ICRU Report 50. Bethesda: 1993:1-8.
14. C.T. Lee L. Dong A.W. Ahamad, et al. 2005 Comparison of treatment volumes and techniques in prostate cancer radiation therapy Am J Clin Oncol 28 618 625 16317275 10.1097/01.coc.0000172281.32437.d4 (Pubitemid 41790017)
15. G. Luxton S.L. Hancock A.L. Boyer, et al. 2004 Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate Int J Radiat Oncol Biol Phys 59 267 284 15093924 10.1016/j.ijrobp.2004.01.024 (Pubitemid 38501532)
16. J.M. Michalski K. Winter J.A. Purdy, et al. 2005 Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V Int J Radiat Oncol Biol Phys 62 706 703 15936549 10.1016/j.ijrobp.2004.11.028 (Pubitemid 40779758)
17. A.W. Partin L.A. Mangold D.M. Lamm, et al. 2001 Comtemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium Urology 58 843 848 11744442 10.1016/S0090-4295(01)01441-8 1:STN:280: DC%2BD3MnpvV2htg%3D%3D (Pubitemid 34017254)
18. M. Pinkawa R. Holy M.D. Piroth, et al. 2010 Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study Radiat Oncol 5 27 20377874 10.1186/1748-717X-5-27
19. M. Pinkawa R. Holy M.D. Piroth, et al. 2010 Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost Strahlenther Onkol 186 600 606 20936457 10.1007/s00066-010-2122-5
20. M. Pinkawa M.D. Piroth K. Fischedick, et al. 2009 Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer Strahlenther Onkol 185 724 370 19899005 10.1007/s00066-009- 2008-6
21. Pinkawa M, Piroth MD, Holy R et al. Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison. Int J Radiat Oncol Biol Phys 2010 (in press).
22. M. Pinkawa M. Pursch-Lee B. Asadpour, et al. 2008 Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion Strahlenther Onkol 184 679 685 19107350 10.1007/s00066-008-1902-7
23. M. Pinkawa J. Siluschek B. Gagel, et al. 2007 Postoperative radiotherapy for prostate cancer: evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy) Strahlenther Onkol 183 23 29 17225942 10.1007/s00066-007-1588-2 (Pubitemid 46144102)
24. G.J. van der Wielen W.L. van Putten L. Incrocci, et al. 2007 Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial Int J Radiat Oncol Biol Phys 68 479 484 17331667 10.1016/j.ijrobp.2006.12.015 (Pubitemid 46694167)
25. G.A. Viani E.J. Stefano S.L. Alfonso 2009 Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials Int J Radiat Oncol Biol Phys 74 1405 1418 19616743 10.1016/j.ijrobp.2008.10.091
26. E. Volz-Sidiropoulou M. Pinkawa K. Fischedick, et al. 2008 Factor analysis of the Expanded Prostate Cancer Index Composite (EPIC) in a patient group after primary (external beam radiotherapy and permanent iodine-125 brachytherapy) and postoperative radiotherapy for prostate cancer Curr Urol 2 122 129 10.1159/000189652
27. D. Vordermark M. Schwab R. Ness-Dourdoumas, et al. 2003 Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate Radiother Oncol 69 209 214 14643960 10.1016/j.radonc.2003.07.002 (Pubitemid 37485882)
28. J.T. Wei R.L. Dunn M.S. Litwin, et al. 2000 Development and validation of the expanded prostate cancer index composite (epic) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 56 899 905 11113727 10.1016/S0090-4295(00)00858-X 1:STN:280: DC%2BD3M7hsFCjtw%3D%3D
29. R. Yaparpalvi L. Hong D. Mah, et al. 2009 ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription Radiother Oncol 89 347 352 10.1016/j.radonc.2008.07.025
30. M.J. Zelefsky E.J. Levin M. Hunt, et al. 2008 Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 1124 1129 18313526 10.1016/j.ijrobp.2007.11.044 (Pubitemid 351296130)